Effect of oral probiotic versus placebo on the improvement of the clinical symptoms in the patients with psoriasis
Phase 2
- Conditions
- Psoriasis.Psoriasis
- Registration Number
- IRCT20120215009014N323
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Age of 18 to 60 years,
Mild to moderate psoriasis,
Involvement of more than 10% of the body surface
Exclusion Criteria
Taking probiotic in the past 6 weeks,
Diabetes,
Immunodeficiency disorder,
Taking immunosuppressive drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psoriasis Area and Severity Index (PASI). Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Through clinical examination.;Dermatology Life Quality Index (DLQI). Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Through clinical examination.;Itching severity. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: Using Visual Analog Scale (VAS).
- Secondary Outcome Measures
Name Time Method